Free Trial

Harmony Biosciences (HRMY) Earnings Date, Estimates & Call Transcripts

Harmony Biosciences logo
$35.19 +0.06 (+0.17%)
(As of 11:50 AM ET)

Harmony Biosciences Latest Earnings Summary

Upcoming Q4
Earnings Date
Feb. 27Estimated
Actual EPS
(Oct. 29)
$0.79 Beat By $0.15
Consensus EPS
(Oct. 29)
$0.64

Harmony Biosciences released Q3 2024 earnings on October 29, 2024, reporting an EPS of $0.79, which topped analysts' consensus estimates of $0.64 by $0.15. Quarterly revenue rose 16.0% year-over-year to $186 million, above the consensus estimate of $184.07 million. With a trailing EPS of $2.11 and a P/E Ratio of 16.68, Harmony Biosciences' earnings are expected to grow 11.86% next year, from $2.36 to $2.64 per share.

HRMY Upcoming Earnings

Harmony Biosciences' next earnings date is estimated for Thursday, February 27, 2025, based off prior year's reporting schedules.

Get Harmony Biosciences Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Harmony Biosciences and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

HRMY Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

HRMY Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Harmony Biosciences Analyst EPS Estimates

Current Year EPS Consensus Estimate:$2.36 EPS
Next Year EPS Consensus Estimate: $2.64 EPS

Harmony Biosciences Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
2/27/2025
(Estimated)
-------
10/29/2024Q3 2024$0.64$0.79+$0.15$0.79$184.07M$186.00M
8/6/2024Q2 2024-$0.04$0.20+$0.24$0.20$172.53M$172.80M
4/30/2024Q1 2024$0.60$0.67+$0.07$0.67$154.10M$154.62M
2/22/2024Q4 2023$0.74$0.45 -$0.29$0.45$168.90M$168.40M
10/31/2023Q3 2023$0.67$0.63 -$0.04$0.63$147.83M$160.30M
8/1/2023Q2 2023$0.62$0.56 -$0.06$0.56$139.79M$134.22M
5/2/2023Q1 2023$0.44$0.48+$0.04$0.48$118.21M$119.13M
2/21/2023Q4 2022$0.54$1.01+$0.47$1.23$127.73M$128.31M

Harmony Biosciences Earnings - Frequently Asked Questions

Harmony Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 27th, 2025 based off last year's report dates. Learn more on HRMY's earnings history.

Harmony Biosciences issued an update on its FY 2024 earnings guidance on Tuesday, October, 29th. The company issued revenue guidance of $700.0 million-$720.0 million, compared to the consensus revenue estimate of $710.1 million.

In the previous quarter, Harmony Biosciences (NASDAQ:HRMY) reported $0.79 earnings per share (EPS) to beat the analysts' consensus estimate of $0.64 by $0.15. Learn more on analysts' earnings estimate vs. HRMY's actual earnings.

The conference call for Harmony Biosciences's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Harmony Biosciences's latest earnings report can be read online.
Read Transcript

Harmony Biosciences (NASDAQ:HRMY) has a recorded annual revenue of $582.02 million.

Harmony Biosciences (NASDAQ:HRMY) has a recorded net income of $128.85 million. HRMY has generated $2.11 earnings per share over the last four quarters.

Harmony Biosciences (NASDAQ:HRMY) has a trailing price-to-earnings ratio of 16.68 and a forward price-to-earnings ratio of 14.91. The price/earnings-to-growth ratio is 0.64.

Harmony Biosciences's earnings are expected to grow from $2.36 per share to $2.64 per share in the next year, which is a 11.86% increase.

More Earnings Resources from MarketBeat



This page (NASDAQ:HRMY) was last updated on 12/3/2024 by MarketBeat.com Staff
From Our Partners